Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.
Am Heart J
; 246: 136-143, 2022 04.
Article
en En
| MEDLINE
| ID: mdl-34986394
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
COVID-19
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Am Heart J
Año:
2022
Tipo del documento:
Article